Satellos Bioscience MSLE
NASDAQ MSLE
$6.70 -0.30 (-4.29%)
At close: Oct 21, 2026 · 4:00 PM EDT

Satellos Bioscience (MSLE) Non-Current Assets (2023 - 2026)

Updated

Satellos Bioscience's Non-Current Assets came in at $7,000 for the quarter ended Jun 30, 2026, down 12.5% from the prior quarter.

Analysis

Satellos Bioscience (MSLE) Non-Current Assets (2023 - 2026) Analysis & Trends

As of Dec 31, 2025, Satellos Bioscience's Non-Current Assets was $5,000, up 39.7% from the prior year.

  • Going back by year, Non-Current Assets was $3,579 in the year ended Dec 31, 2024 (-99.9%) and $2.92 million in the year ended Dec 31, 2023.
  • The five-year range for quarterly Non-Current Assets is $3,579 (the quarter ended Dec 31, 2024) to $2.92 million (the quarter ended Dec 31, 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 77.61 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 141.29 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 101.45 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 125.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 87.87 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 35.42 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 159.77 Bn
10 Satellos Bioscience 98.81 Mn -109.33 Mn - 7,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7,000.00
Mar 31, 2026 8,000.00
Dec 31, 2025 5,000.00
Dec 31, 2024 3,484.37
Dec 31, 2023 3.01 Mn
API Access

Satellos Bioscience Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=MSLE&period=max&api_key=YOUR_API_KEY